Hydrocortisone acetate is a clinically common synthetic glucocorticoid with anti-inflammatory, anti-allergic and immunosuppressive effects. It is widely used for the treatment of adrenal insufficiency, autoimmune diseases, allergic disorders and other conditions. While this medication delivers definite therapeutic effects, long-term or regular oral intake may exert multi-system impacts on the human body and trigger adverse reactions of varying severity. The severity of side-effects is closely correlated with dosage, treatment duration and individual physical conditions. Short-term low-dose administration usually causes mild adverse reactions, whereas long-term high-dose treatment carries significantly elevated risks. This article categorizes and elaborates on its major side-effects to help patients scientifically manage medication-related risks.
1. Gastrointestinal Side-Effects
The digestive system is one of the most vulnerable systems affected by glucocorticoids and presents the most common adverse reactions during treatment. Hydrocortisone acetate stimulates excessive secretion of gastric acid and pepsin, while impairing the protective and reparative capacity of the gastric mucosa and breaking down the gastric mucosal barrier. Most patients develop mild gastrointestinal discomfort, including abdominal distension, acid regurgitation, belching, increased appetite and dull gastric pain.
Long-term users face higher risks of chronic gastritis, gastric ulcer and duodenal ulcer. In severe cases, gastric mucosal erosion and gastrointestinal haemorrhage may occur, manifested as critical symptoms such as melaena and haematemesis. To reduce risks, oral administration after meals rather than on an empty stomach is generally recommended clinically. Spicy, cold, irritant food and alcohol should be strictly avoided during treatment. Prompt medical intervention is required in case of persistent stomachache or refractory acid regurgitation.
2. Metabolic and Endocrine Side-Effects
Hydrocortisone acetate interferes with carbohydrate, lipid and water-electrolyte metabolism and disrupts endocrine homeostasis, resulting in a spectrum of metabolic abnormalities. Disturbed glucose metabolism is most prevalent. The drug inhibits insulin action and promotes gluconeogenesis, leading to elevated blood glucose and even steroid-induced diabetes. Diabetics tend to experience marked blood-glucose fluctuations after treatment initiation.
Abnormal lipid metabolism causes fat redistribution and typical hormone-related body changes, such as central obesity, moon-shaped face and buffalo hump with relatively slender limbs. Additional manifestations may include subcutaneous fat accumulation and aggravated acne. Impaired water-salt metabolism gives rise to water-sodium retention, resulting in oedema, mild blood-pressure elevation and hypokalaemia, with possible symptoms including fatigue and limb numbness. Furthermore, long-term administration may suppress endogenous adrenal function and cause adrenal cortical atrophy. Abrupt discontinuation will trigger hormonal disturbances.
3. Immune-System and Musculoskeletal Side-Effects
As an immunosuppressant, hydrocortisone acetate broadly lowers immunity. While suppressing inflammatory responses, it weakens the body's defence against bacterial, viral and fungal pathogens. Patients are more susceptible to infectious diseases such as colds, respiratory-tract infections and skin infections during treatment. Infections tend to recover slowly and recur frequently. Severe occult infections with no obvious fever or red-swelling signs may occur and thus be left undiagnosed.
In terms of the musculoskeletal system, long-term medication inhibits osteoblast activity, accelerates calcium loss and impedes bone calcium deposition, leading to osteoporosis and reduced bone mineral density. Middle-aged, elderly and paediatric patients are at higher risk, and severe complications such as vertebral compression fractures may develop. Associated symptoms may include muscular atrophy, limb weakness and arthralgia. For patients on long-term therapy, routine calcium and vitamin-D supplementation, moderate physical exercise and regular bone-mineral-density screening are clinically advised.
4. Cutaneous and Neurological Side-Effects
Skin-related adverse reactions are mostly visible. Apart from aggravated acne, patients may develop skin thinning, telangiectasia, facial flushing, hyperpigmentation and hirsutism. Some individuals suffer from dry skin, pruritus and heightened skin sensitivity. Bruises and ecchymoses may easily form after minor trauma.
Neurologically, the drug affects central-nervous-system functions. Most patients experience insomnia, vivid dreams, irritability, anxiety and mood swings. A small subset may develop dizziness, headache and poor concentration. Very few patients receiving long-term high-dose therapy may present psychiatric abnormalities such as euphoria, irritability or hallucinations. Most symptoms will gradually subside after drug withdrawal.
5. Core Medication Precautions
The most critical principle for oral hydrocortisone acetate is never to adjust the dosage or discontinue treatment abruptly without medical permission. After long-term administration, the human body adapts to exogenous hormones. Sudden cessation will trigger withdrawal reactions characterised by fatigue, low-grade fever, nausea, arthralgia and disease rebound. All dose adjustments and drug withdrawal must be tapered off gradually under physician guidance. Indicators including blood glucose, blood pressure, serum electrolytes and bone mineral density shall be monitored periodically throughout treatment. Seek medical care promptly once discomfort occurs so as to minimise medication-related risks.
